Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0001567619-21-015084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-11 | 2021-08-09 | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $4.31 | +1,500 | 100.3K | +2% | +$6,465 |
| DM | 2021-08-11 | 2021-08-09 | IDYA | Dillon Michael P. | SVP, CSO | S - Sale+OE | $22.98 | -11.5K | 89.2K | -11% | -$264.3K |
| D | 2021-08-11 | 2021-08-09 | IDYA | Dillon Michael P. | SVP, CSO | M - OptEx | $0.00 | -1,500 | 66.2K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | M | A | 1,500 | $4.31 | 100,289 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-09 | S | D | 400 | $23.52 | 88,789 | D | — | — | (F3) This transaction was executed in multiple trades in prices ranging from $23.49 to $23.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-08-09 | S | D | 11,100 | $22.96 | 89,189 | D | — | — | (F2) This transaction was executed in multiple trades in prices ranging from $22.48 to $23.46, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-08-09 | M | D | 1,500 | $0.00 | 66,235 | D | $4.31 · — to 2028-02-26 | 1,500 Common Stock | (F4) 25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |